Drug Type Small molecule drug |
Synonyms prasugrel, prasugrel besilate, Prasugrel hydrochloride (JAN/USAN) + [12] |
Target |
Action antagonists |
Mechanism P2Y12 receptor antagonists(Purinergic receptor P2Y12 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date European Union (24 Feb 2009), |
RegulationOrphan Drug (United States) |
Molecular FormulaC20H21ClFNO3S |
InChIKeyJALHGCPDPSNJNY-UHFFFAOYSA-N |
CAS Registry389574-19-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D05597 | Prasugrel Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Brain Ischemia | Japan | 24 Dec 2021 | |
Angina, Stable | Japan | 24 Mar 2014 | |
Myocardial Infarction | Japan | 24 Mar 2014 | |
Acute Coronary Syndrome | European Union | 24 Feb 2009 | |
Acute Coronary Syndrome | Iceland | 24 Feb 2009 | |
Acute Coronary Syndrome | Liechtenstein | 24 Feb 2009 | |
Acute Coronary Syndrome | Norway | 24 Feb 2009 | |
Angina, Unstable | European Union | 24 Feb 2009 | |
Angina, Unstable | Iceland | 24 Feb 2009 | |
Angina, Unstable | Liechtenstein | 24 Feb 2009 | |
Angina, Unstable | Norway | 24 Feb 2009 | |
Non-St Elevated Myocardial Infarction | European Union | 24 Feb 2009 | |
Non-St Elevated Myocardial Infarction | Iceland | 24 Feb 2009 | |
Non-St Elevated Myocardial Infarction | Liechtenstein | 24 Feb 2009 | |
Non-St Elevated Myocardial Infarction | Norway | 24 Feb 2009 | |
ST Elevation Myocardial Infarction | European Union | 24 Feb 2009 | |
ST Elevation Myocardial Infarction | Iceland | 24 Feb 2009 | |
ST Elevation Myocardial Infarction | Liechtenstein | 24 Feb 2009 | |
ST Elevation Myocardial Infarction | Norway | 24 Feb 2009 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anemia, Sickle Cell | Phase 3 | United States | 01 Apr 2013 | |
Anemia, Sickle Cell | Phase 3 | Belgium | 01 Apr 2013 | |
Anemia, Sickle Cell | Phase 3 | Brazil | 01 Apr 2013 | |
Anemia, Sickle Cell | Phase 3 | Canada | 01 Apr 2013 | |
Anemia, Sickle Cell | Phase 3 | Egypt | 01 Apr 2013 | |
Anemia, Sickle Cell | Phase 3 | Ghana | 01 Apr 2013 | |
Anemia, Sickle Cell | Phase 3 | Italy | 01 Apr 2013 | |
Anemia, Sickle Cell | Phase 3 | Kenya | 01 Apr 2013 | |
Anemia, Sickle Cell | Phase 3 | Lebanon | 01 Apr 2013 | |
Anemia, Sickle Cell | Phase 3 | Oman | 01 Apr 2013 |
Not Applicable | - | - | - | 02 Sep 2024 | |||
Not Applicable | - | dwagxprxxi(hshihfyeyh) = brtqrnjtkn uizuwhjoxk (sexssxrrqi ) | Positive | 02 Sep 2024 | |||
dwagxprxxi(hshihfyeyh) = coycibkyku uizuwhjoxk (sexssxrrqi ) | |||||||
Not Applicable | - | nkdvgfcdxl(bjqfvsmmjq) = rqpgydpmdr jctnuibxlt (cwquaijkqh ) | - | 01 Sep 2024 | |||
Not Applicable | - | Prasugrel monotherapy (3.75mg/day) | ylnfkmrtrj(edqapxbans) = gpjbhlyici nesliwzxmw (xwawoqczyn ) View more | - | 01 Sep 2024 | ||
Not Applicable | - | Standard dose ticagrelor | lekckdxohp(qitesfafvb) = umpqjojvmb ppbvfnwogy (sjvmydouaq ) View more | Positive | 01 Sep 2024 | ||
Reduced dose prasugrel | lekckdxohp(qitesfafvb) = alvklantim ppbvfnwogy (sjvmydouaq ) View more | ||||||
Not Applicable | - | 780 | kuzpfvpdga(fqtsblmttd) = pwyshrowxs zswlvkqzat (unhegqdzog ) View more | Positive | 31 Aug 2024 | ||
Not Applicable | - | koamfemyxh(fsxoxprzbk): HR = 0.67 (95% CI, 0.47 - 0.95) View more | - | 30 Aug 2024 | |||
Not Applicable | - | rmtfsrfzjw(sktlquupqg) = xbgxmaonoc uugjysgbgb (jiwfrbaruu ) | - | 30 Aug 2024 | |||
rmtfsrfzjw(sktlquupqg) = ngyoufbbso uugjysgbgb (jiwfrbaruu ) | |||||||
Phase 4 | 359 | (Prasugrel) | dmqeszhqca(wklctspqjm) = mxfxuwggkw aemgvbojuj (ueamomivyw, 31) View more | - | 20 Mar 2024 | ||
dmqeszhqca(wklctspqjm) = pwefqzdesz aemgvbojuj (ueamomivyw, 104) View more | |||||||
Phase 4 | 98 | (Genotype-Guided Therapy) | iwbdasiivp = ndpqynztuf mlzcnowlvo (oovnohojdl, alzzbkvwqb - negairbqem) View more | - | 21 Feb 2024 | ||
(Conventional Therapy) | iwbdasiivp = vvadjpmtjc mlzcnowlvo (oovnohojdl, jmllypvdyk - kegvqovcpx) View more |